OSCR Stock Price, Oscar Health, Inc. Quote, Chart

Market Summary

USD17.61+0.21

Market Closed

1.21%

OSCR Stock Price

View Fullscreen

OSCR RSI Chart

OSCR Valuation

Market Cap

3.9B

Price/Earnings (Trailing)

-14.42

Price/Sales (Trailing)

0.67

EV/EBITDA

-11

Price/Free Cashflow

-14.34

OSCR Price/Sales (Trailing)

OSCR Profitability

EBT Margin

-4.56%

Return on Equity

-33.66%

Return on Assets

-7.51%

Free Cashflow Yield

-6.97%

OSCR Fundamentals

OSCR Revenue

Revenue (TTM)

5.9B

Rev. Growth (Yr)

43.87%

Rev. Growth (Qtr)

-0.58%

OSCR Earnings

Earnings (TTM)

-270.6M

Earnings Growth (Yr)

33.26%

Earnings Growth (Qtr)

-129.6%

Breaking Down OSCR Revenue

Last 7 days

11.0%

Last 30 days

29.0%

Last 90 days

48.9%

Trailing 12 Months

197.6%

How does OSCR drawdown profile look like?

OSCR Financial Health

Current Ratio

1.26

Debt/Equity

0.37

Debt/Cashflow

-0.91

OSCR Investor Care

Shares Dilution (1Y)

4.32%

Diluted EPS (TTM)

-1.22

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	4.5B	5.0B	5.4B	5.9B
2022	2.4B	2.9B	3.4B	4.0B
2021	1.9B	2.2B	2.4B	1.8B
2020	1.2B	1.4B	1.5B	1.7B
2019	0	0	0	1.0B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Oscar Health, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 03, 2024	bertolini mark t	acquired	-	-	955,555	chief executive officer
Mar 06, 2024	blackley richard scott	sold	-381,847	14.12	-27,043	chief financial officer
Mar 06, 2024	quane alessandrea c.	sold	-186,850	14.12	-13,233	evp, chief insurance officer
Mar 05, 2024	quane alessandrea c.	acquired	-	-	31,250	evp, chief insurance officer
Mar 05, 2024	blackley richard scott	acquired	-	-	62,500	chief financial officer
Mar 04, 2024	blackley richard scott	sold	-227,814	15.88	-14,346	chief financial officer
Mar 04, 2024	quane alessandrea c.	sold	-252,937	15.88	-15,928	evp, chief insurance officer
Mar 04, 2024	baltrus victoria	sold	-535,267	15.88	-33,707	chief accounting officer
Mar 04, 2024	bopitiya ranmali	sold	-181,445	15.88	-11,426	evp & chief legal officer
Mar 01, 2024	baltrus victoria	acquired	-	-	16,432	chief accounting officer

Which funds bought or sold OSCR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Summit Trail Advisors, LLC	added	9.51	128,691	293,757	0.01%
Apr 23, 2024	AMALGAMATED BANK	reduced	-62.88	-52,000	78,000	-%
Apr 22, 2024	Raymond James Financial Services Advisors, Inc.	added	11.83	100,223	222,842	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	294,333	752,276	-%
Apr 19, 2024	Cutler Group LLC / CA	sold off	-100	-1,000	-	-%
Apr 19, 2024	DENALI ADVISORS LLC	reduced	-57.08	-664	1,532	-%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	new	-	4,117,100	4,117,100	0.01%
Apr 18, 2024	LVW Advisors, LLC	reduced	-19.8	58,312	250,545	0.04%
Apr 15, 2024	WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	new	-	158,128	158,128	-%
Apr 15, 2024	Counterpoint Mutual Funds LLC	reduced	-2.15	270,419	728,541	0.18%

Are Funds Buying or Selling OSCR?

Are funds buying OSCR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own OSCR

No. of Funds

Unveiling Oscar Health, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	dragoneer investment group, llc	6.7%	12,725,999	SC 13G
Feb 14, 2024	general catalyst group management holdings gp, llc	1.1%	2,107,719	SC 13G/A
Feb 14, 2024	khosla ventures iv, l.p.	2.4%	4,564,404	SC 13G/A
Feb 13, 2024	vanguard group inc	7.47%	14,244,912	SC 13G/A
Feb 12, 2024	flynn james e	5.89%	11,246,820	SC 13G/A
Feb 02, 2024	capitalg 2015 lp	0.0%	0	SC 13G/A
Jan 26, 2024	blackrock inc.	7.5%	14,351,597	SC 13G/A
Jan 10, 2024	southeastern asset management inc/tn/	3.0%	571	SC 13G/A
Dec 01, 2023	flynn james e	5.52%	10,537,491	SC 13G
Feb 14, 2023	southeastern asset management inc/tn/	8.1%	145	SC 13G/A

Recent SEC filings of Oscar Health, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 15, 2024	4	Insider Trading
Apr 05, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 07, 2024	144	Notice of Insider Sale Intent
Mar 07, 2024	4	Insider Trading
Mar 07, 2024	4	Insider Trading

Peers (Alternatives to Oscar Health, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	-0.74%	-0.51%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	0.26%	37.72%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-12.72%	-6.73%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-3.19%	11.59%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.43%	12.08%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-0.12%	51.97%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-8.62%	17.22%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.26	4.12	6.06%	9.17%
ACHC	6.6B	2.9B	-7.52%	-4.24%	-303.27	2.24	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	33.83	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.76	0.42	6.74%	20.73%
BEAT	53.7M	-	-3.27%	-3.72%	-3.67	-	-	-12.94%
AMS	18.7M	21.3M	13.26%	5.28%	35.15	0.88	8.00%	-62.25%

Oscar Health, Inc. News

Latest updates

Oscar Health, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	-0.6%	1,431,658,000	1,439,991,000	1,521,535,000	1,469,685,000	995,127,000	978,427,000	1,017,319,000	972,765,000	823,112,500	673,460,000	723,927,000	610,099,000	439,846,000	414,505,000	393,540,000	424,448,000	-
S&GA Expenses	13.4%	85,610,000	75,503,000	76,453,000	102,150,000	75,808,000	78,557,000	80,754,000	74,664,000	89,337,000	60,003,000	51,166,000	64,572,000	62,276,000	36,546,000	35,994,000	31,839,000	-
EBITDA Margin	33.0%	-0.04	-0.05	-0.07	-0.09	-0.11	-0.15	-0.17	-0.17	-0.20	-0.18	-0.16	-0.17	-0.20	-0.14	-0.17	-0.20	-0.24
Interest Expenses	1.4%	6,217,000	6,130,000	6,120,000	6,136,000	6,135,000	6,126,000	6,141,000	4,221,000	397,000	398,000	228,000	3,697,000	3,514,000	-	-	-	-
Income Taxes	-188.1%	-806,000	915,000	1,164,000	2,021,000	-715,000	-1,615,000	290,000	1,517,000	-111,000	-597,000	589,000	965,000	-481,000	-998,000	1,593,000	931,000	-
Earnings Before Taxes	-132.5%	-150,644,000	-64,788,000	-14,261,000	-37,607,000	-227,275,000	-195,162,000	-111,835,000	-75,803,000	-197,852,000	-212,078,000	-72,734,000	-87,916,000	-190,351,000	-80,130,000	-39,351,000	-95,948,000	-
EBT Margin	28.1%	-0.05	-0.06	-0.07	-0.10	-0.11	-0.16	-0.18	-0.18	-0.21	-0.18	-0.17	-0.18	-0.20	-0.15	-0.17	-0.20	-0.25
Net Income	-129.6%	-150,153,500	-65,398,000	-15,425,000	-39,628,000	-224,981,500	-192,913,000	-112,125,000	-77,320,000	-198,921,000	-211,481,000	-73,323,000	-88,881,000	-189,870,000	-79,132,000	-40,944,000	-96,879,000	-
Net Income Margin	27.5%	-0.05	-0.06	-0.07	-0.10	-0.11	-0.16	-0.18	-0.18	-0.21	-0.18	-0.17	-0.18	-0.21	-0.15	-0.17	-0.20	-0.25
Free Cashflow	125.8%	296,868,000	-1,149,266,000	165,524,000	414,715,000	151,394,000	-548,361,000	214,467,000	562,849,000	34,479,000	-589,252,000	55,337,000	317,691,000	88,983,000	-218,923,000	246,322,000	106,350,000	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet													(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	7.5%	3,601	3,350	4,565	4,483	4,527	4,309	4,751	4,351	3,322	3,170	3,706	3,594	2,272
Current Assets	2.3%	3,061	2,992	4,193	4,131	4,122	3,931	4,260	3,675	2,306	2,241	2,816	3,179	1,870
Cash Equivalents	33.6%	1,870	1,400	2,322	2,110	1,559	2,113	2,363	2,069	1,104	1,077	1,672	2,321	843
Net PPE	-0.1%	62.00	62.00	63.00	64.00	60.00	56.00	51.00	49.00	47.00	43.00	41.00	39.00	36.00
Liabilities	15.1%	2,795	2,428	3,613	3,551	3,634	3,224	3,503	3,015	1,929	1,617	1,973	1,808	1,823
Current Liabilities	17.9%	2,429	2,061	3,244	3,182	3,264	2,853	3,130	2,641	1,852	1,617	1,973	1,808	1,666
Long Term Debt	0.1%	299	299	298	298	298	298	298	297	-	-	-	-	142
LT Debt, Non Current	0.1%	299	299	298	298	298	298	298	297	-	-	-	-	142
Shareholder's Equity	-12.6%	804	919	952	932	890	1,085	1,248	1,335	1,393	1,553	1,732	1,785	-1,295
Retained Earnings	-5.5%	-2,876	-2,726	-2,661	-2,645	-2,605	-2,379	-2,187	-2,074	-1,999	-1,800	-1,587	-1,514	-1,427
Additional Paid-In Capital	0.8%	3,682	3,654	3,621	3,583	3,509	3,479	3,450	3,422	3,394	3,356	3,324	3,303	133
Shares Outstanding	-0.6%	222	223	219	217	212	212	211	211	179	169	207	89.00	29.00
Minority Interest	9.8%	2.00	2.00	2.00	2.00	2.00	3.00	3.00	3.00	5.00	-	-	-	-
Float	-	-	-	1,500	-	-	-	728	-	-	-	3,386	-	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																	(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	125.8%	297	-1,149	166	415	151	-548	214	563	34.00	-589	55.00	318	89.00	-218	246	106	-
Share Based Compensation	-9.1%	26.00	29.00	33.00	71.00	29.00	29.00	27.00	28.00	28.00	21.00	18.00	19.00	14.00	7.00	7.00	8.00	-
Cashflow From Investing	-23.4%	172	225	44.00	136	-706	299	79.00	103	-19.84	-12.36	-708	-34.28	15.00	-433	26.00	48.00	-
Cashflow From Financing	-53.9%	1.00	2.00	3.00	1.00	1.00	0.00	1.00	299	13.00	11.00	3.00	1,212	385	1.00	225	0.00	-

OSCR Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue
Premiums before ceded reinsurance	$ 5,696,978	$ 5,334,520	$ 2,712,988
Reinsurance premiums ceded	(10,909)	(1,463,403)	(881,968)
Premiums earned	5,686,069	3,871,117	1,831,020
Administrative services revenue	15,442	61,047	5,394
Investment income and other revenue	161,358	31,474	2,301
Total revenue	5,862,869	3,963,638	1,838,715
Operating Expenses
Claims incurred, net	4,642,024	3,280,798	1,623,995
Other insurance costs	824,457	706,439	410,363
General and administrative expenses	339,716	309,783	265,078
Federal and state assessments	290,725	281,518	139,085
Premium deficiency reserve (release)	1,562	(25,033)	(55,325)
Total operating expenses	6,098,484	4,553,505	2,383,196
Loss from operations	(235,615)	(589,867)	(544,481)
Interest expense	24,603	22,623	4,720
Other expenses (income)	7,082	(2,415)	1,201
Loss on extinguishment of debt	0	0	20,178
Loss before income taxes	(267,300)	(610,075)	(570,580)
Income tax expense (benefit)	3,294	(523)	846
Net loss	(270,594)	(609,552)	(571,426)
Less: Net income (loss) attributable to noncontrolling interests	134	(3,277)	1,180
Net loss attributable to Oscar Health, Inc.	$ (270,728)	$ (606,275)	$ (572,606)
Earnings (Loss) per Share
Net loss per share attributable to Oscar Health, Inc., basic (in dollars per share)	$ (1.22)	$ (2.85)	$ (3.20)
Net loss per share attributable to Oscar Health, Inc., diluted (in dollars per share)	$ (1.22)	$ (2.85)	$ (3.20)
Weighted average common shares outstanding, basic (in shares)	221,655,493	212,474,615	178,967,056
Weighted-average common shares outstanding, diluted (in shares)	221,655,493	212,474,615	178,967,056

OSCR Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 1,870,315	$ 1,558,595
Short-term investments	689,833	1,397,287
Premiums and accounts receivable (net of allowance for credit losses of $31,600 and $2,988)	201,269	216,475
Risk adjustment transfer receivable	51,925	49,861
Reinsurance recoverable	241,194	892,887
Other current assets	6,564	6,450
Total current assets	3,061,100	4,121,555
Property, equipment, and capitalized software, net	61,930	59,888
Long-term investments	365,309	222,919
Restricted deposits	29,870	27,483
Other assets	83,271	94,756
Total Assets	3,601,480	4,526,601
Current Liabilities:
Benefits payable	965,986	937,727
Risk adjustment transfer payable	1,056,941	1,517,493
Premium deficiency reserve	5,776	4,214
Unearned premiums	65,918	78,998
Accounts payable and other liabilities	273,367	297,841
Reinsurance payable	61,024	427,649
Total current liabilities	2,429,012	3,263,922
Long-term debt	298,777	297,999
Other liabilities	67,574	72,280
Total liabilities	2,795,363	3,634,201
Commitments and contingencies (Note 19)
Stockholders' Equity
Treasury stock (314,600 shares as of December 31, 2023 and 2022)	(2,923)	(2,923)
Additional paid-in capital	3,682,294	3,509,007
Accumulated deficit	(2,876,715)	(2,605,987)
Accumulated other comprehensive income (loss)	1,309	(9,715)
Total Oscar Health, Inc. stockholders’ equity	803,967	890,384
Noncontrolling interests	2,150	2,016
Total stockholders’ equity	806,117	892,400
Total Liabilities and Stockholders' Equity	3,601,480	4,526,601
Class A
Stockholders' Equity
Common stock	2	2
Class B
Stockholders' Equity
Common stock	$ 0	$ 0

About Oscar Health, Inc.

Oscar Health, Inc. operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

CEO	Mr. Mark Thomas Bertolini
WEBSITE	hioscar.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2714

Oscar Health, Inc. Frequently Asked Questions

What is the ticker symbol for Oscar Health, Inc.? What does OSCR stand for in stocks?

OSCR is the stock ticker symbol of Oscar Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Oscar Health, Inc. (OSCR)?

As of Tue Apr 23 2024, market cap of Oscar Health, Inc. is 3.86 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OSCR stock?

You can check OSCR's fair value in chart for subscribers.

What is the fair value of OSCR stock?

You can check OSCR's fair value in chart for subscribers. The fair value of Oscar Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Oscar Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OSCR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Oscar Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether OSCR is over valued or under valued. Whether Oscar Health, Inc. is cheap or expensive depends on the assumptions which impact Oscar Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OSCR.

What is Oscar Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, OSCR's PE ratio (Price to Earnings) is -14.25 and Price to Sales (PS) ratio is 0.66. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OSCR PE ratio will change depending on the future growth rate expectations of investors.